SCHEMBL5766529

SCHEMBL5766529

O=[N+]([O-])c1nc(-c2ccccc2[N+](=O)[O-])c[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
TDP1 Q9NUW8 2/20 0.50
MAOB P27338 1/20 0.48
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
MAPT P10636 3/20 0.46
GUSB P08236 1/20 0.46
F2 P00734 1/20 0.46
C1R P00736 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 2/20 0.44
RAB9A P51151 2/20 0.44
MGAM O43451 2/20 0.43
GAA P10253 2/20 0.43
SI P14410 2/20 0.43
MGAM2 Q2M2H8 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HSD17B10 Q99714 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9206937 0.83 ALDH1A1 (0.47) ALDH1A1TDP1MAOBMEN1KMT2A
Hydrochloric Acid SCHEMBL14988800 0.82 MGAM (0.47) ALDH1A1TDP1MAOBMEN1KMT2A
SCHEMBL12881747 0.81 ALDH1A1 (0.57) ALDH1A1TDP1MAOBMEN1KMT2A
SCHEMBL9876453 0.80 ALDH1A1 (0.46) ALDH1A1TDP1MAOBMEN1KMT2A
SCHEMBL26965121 0.80 ALDH1A1 (0.44) ALDH1A1TDP1MAOBMEN1KMT2A
SCHEMBL28351456 0.79 KMT2A (0.41) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL9767738 0.76 ALDH1A1 (0.56) ALDH1A1TDP1MAOBMEN1KMT2A
SCHEMBL14988958 0.76 ALDH1A1 (0.44) ALDH1A1TDP1MAOBMEN1KMT2A
SCHEMBL14988959 0.76 ALDH1A1 (0.44) ALDH1A1TDP1MAOBMEN1KMT2A
SCHEMBL15270786 0.75 ALDH1A1 (0.53) ALDH1A1TDP1MAOBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613612-A2 BIOREDUCTIVELY-ACTIVATED PRODRUGS Angiogene Pharmaceuticals Limited (GB) 2006-01-11 EP disclosed
WO-2004085421-A2 BIOREDUCTIVELY-ACTIVATED PRODRUGS ANGIOGENE PHARMACEUTICALS LIMITED (GB) 2004-10-07 WO disclosed